Home
Ataxia
Idebenone
Fran?ais
A+
|
A-
|
Reset
Home
About CAFA
Ataxia
How you can help
Membership
Member's Area
Medias & Events
Forum
Contact Us
Links
Search
Member Access
Username
Password
Remember me
Lost Password?
No account yet?
Register
Last articles
Clinical study on HDACIs…
By Guy D’Anjou, M.D.
Research report on Late Onset Cerebellar Ataxia (LOCA)
, by Isabelle Thiffault
Quiz
What Do You Know about Ataxia, Claude St-Jean and CAFA?
Film Project
Your collaboration is welcome.
Donate Hbc Rewards points
The
Hbc Rewards Community Program
allows you to donate your Hbc Rewards points
to the CAFA – Claude St-Jean Foundation.
Idebenone
Press Release. Santhera’s MICONOS Trial with Catena®/Sovrima® in Friedreich’s Ataxia Misses Primary Endpoint
Santhera Pharmaceuticals about preliminary results of the CATENA US clinical trial
Actual Payer Coverage in Canada for CATENA® (idebenone)
Catena®(idebenone): Product Monograph
Catena®(idebenone): Product Monograph. Part III
Catena®: Fact Sheet
Health Canada Approves Catena® for Treatment of Friedreich’s Ataxia. News release
Di Prospero et al.
Neurological effects of high-dose idebenone in patients with Friedreich’s ataxia: a randomised, placebo-controlled trial.
(format PDF)
Idebenone. Research report
(PDF, in French only)
< Prev
Next >
or through
Upcoming events
*****
*****
Links
Promotional Items
Home
|
Sitemap
© 2009 Association Canadienne des Ataxies Familiales
phpMyVisites | Open source web analytics
Ataxia Idebenone
Ataxia Idebenone
Fran?ais
to the CAFA – Claude St-Jean Foundation.
